Government of India
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan, New Delhi-110011
Policy Circular No. 55 (RE-2010)/2009-14
Dated: 29.2.2012
Subject: Conditionality for Import of Erythromycin Thiocyanate under Advance
Authorization Scheme: Applicability of Policy Circular No.9 dated 30.6.2003 and
PC 15 dated 17.9.2003.
Policy Circular No. 9 dated 30.6.2003 and Policy Circular No 15 dated
17.9.2003 prescribe exemption from the registration procedure for imports of
approved and unapproved drugs under Advance Authorisation. The issue whether
Erythromycin Thiocyanate falls under the purview of these Circulars or not, has
been examined in consultation with the Drugs Controller General of India (DCGI).
- It is hereby clarified that the import of Erythromycin Thiocyanate
for manufacturing and export of ‘Erythromycin Salts’ under Advance
Authorisation Scheme is exempt from the conditionalities imposed under
Policy Circular No. 9 dated 30.6.2003 and Policy Circular No. 15 dated
17.9.2003. In such cases, only the normal conditions of Advance
Authorisation will apply.
- In case the import of Erythromycin Thiocyanate is for veterinary
medicinal use or for manufacturing of any drug under Advance Authorisation,
then the conditions of the Policy Circulars No. 9 dated 30.6.2003 and No. 15
dated 17.9.2003 shall apply, in addition to normal condition for all Advance
Authorisations.
This issues with the approval of competent authority.
Sd/-
(C. Gangadharan)
Dy. Director General of Foreign Trade
Tele No. 23061562 Ext.250
Email: [email protected]
(Issued from F. No. 01/94/180/192/AM’12/PC-IV)